Duisburg

Emergence Therapeutics raises €87 million Series A financing to advance Nectin-4 ADC

Retrieved on: 
Tuesday, December 7, 2021

Emergence Therapeutics AG, a biopharmaceutical company developing novel antibody drug conjugates (ADC) for the treatment of cancers with high unmet needs, today announces that it has closed an 87 million series A financing round.

Key Points: 
  • Emergence Therapeutics AG, a biopharmaceutical company developing novel antibody drug conjugates (ADC) for the treatment of cancers with high unmet needs, today announces that it has closed an 87 million series A financing round.
  • Proceeds from this funding round will be used to advance the companys next-generation antibody drug conjugate (ADC) targeting Nectin-4 to clinical proof-of-concept as well as the development of additional ADC programs.
  • Emergences lead asset, ETx-22, is a next-generation Nectin-4 ADC which has been optimized to increase efficacy and minimize toxicity.
  • Jack Elands, CEO of Emergence Therapeutics, commented: The completion of this significantly oversubscribed round enables Emergence to execute on its strategy to become a dominant ADC developer.

Emergence Therapeutics raises €87 million Series A financing to advance Nectin-4 ADC

Retrieved on: 
Tuesday, December 7, 2021

Emergence Therapeutics AG, a biopharmaceutical company developing novel antibody drug conjugates (ADC) for the treatment of cancers with high unmet needs, today announces that it has closed an 87 million series A financing round.

Key Points: 
  • Emergence Therapeutics AG, a biopharmaceutical company developing novel antibody drug conjugates (ADC) for the treatment of cancers with high unmet needs, today announces that it has closed an 87 million series A financing round.
  • Proceeds from this funding round will be used to advance the companys next-generation antibody drug conjugate (ADC) targeting Nectin-4 to clinical proof-of-concept as well as the development of additional ADC programs.
  • Emergences lead asset, ETx-22, is a next-generation Nectin-4 ADC which has been optimized to increase efficacy and minimize toxicity.
  • Jack Elands, CEO of Emergence Therapeutics, commented: The completion of this significantly oversubscribed round enables Emergence to execute on its strategy to become a dominant ADC developer.

DGAP-News: Corestate subsidiary Hannover Leasing successfully places CityPalais in Duisburg

Retrieved on: 
Friday, November 20, 2020

Hannover Leasing, a subsidiary of the real estate investment manager Corestate Capital Group (Corestate), has successfully placed, despite the challenging market environment, the Duisburg CityPalais.

Key Points: 
  • Hannover Leasing, a subsidiary of the real estate investment manager Corestate Capital Group (Corestate), has successfully placed, despite the challenging market environment, the Duisburg CityPalais.
  • The mixed-use property, so far in a closed-end public fund managed by Hannover Leasing, was completed in 2007 and had previously been acquired as part of a so-called forward purchase.
  • Nils Hbener, CIO of Corestate: "It was clear to us from the outset that the CityPalais is of great importance for the region surrounding Duisburg.
  • The CityPalais has 37,700 m of rentable space and an underground car park with 649 parking spaces.

Huawei Deepens Cooperation with Duisburg to Transform Germany's Industrial Heartland into a Smart City

Retrieved on: 
Monday, September 3, 2018

Their cooperation will focus on transforming Duisburg from a traditional industrial city into a service-oriented smart city through smart government, smart port logistics, smart education, smart infrastructure, 5G and broadband, smart homes, and urban IoT.

Key Points: 
  • Their cooperation will focus on transforming Duisburg from a traditional industrial city into a service-oriented smart city through smart government, smart port logistics, smart education, smart infrastructure, 5G and broadband, smart homes, and urban IoT.
  • At CEBIT held in Germany in June 2018, Huawei and Duisburger Versorgungs- und Verkehrsgesellschaft mbH (DVV) signed a Framework Agreement on the "Rhine Cloud" the brand name of a smart city and public service cloud platform and Smart City services, enabling Duisburg to move towards its goal of becoming a smart city.
  • Mayor Sren Link said: "We're happy to work with Huawei to transform Duisburg to a smart city.
  • A smart city nervous system network will be built to advance transportation, logistics, and industrial manufacturing, enabling smart living, autonomous driving and smart city operations.

Huawei and DU-IT Help Duisburg Become a Smart City

Retrieved on: 
Monday, June 11, 2018

The agreement expands the cooperation of the two companies and strengthens their joint efforts to enable Duisburg to become a smart city.

Key Points: 
  • The agreement expands the cooperation of the two companies and strengthens their joint efforts to enable Duisburg to become a smart city.
  • Both Huawei and the DU-IT GmbH are part of the network "Smart City Duisburg".
  • We are delighted to be Duisburg's preferred partner for developing a smart city and this cooperation will build on our success of delivering smart city deployments worldwide.
  • The introduction of Rhine Cloud, the brand name for a Smart City and Public Services Cloud Platform, represents a significant step towards making Duisburg a smart city, providing the capabilities to support city automation and intelligence.